PECAM1 and breast cancer: Pearson’s correlation coefficients showed that Biglycan mRNA expression was positively correlated with both PECAM1(Spearman’s correlation = 0.45) and ANGPT2 (Spearman’s correlation = 0.4) levels in human breast cancers (Fig. 1e, f).